CJC-1295 with DAC binds growth hormone-releasing hormone receptor (GHRH-R), a Gs-coupled receptor whose activation drives cyclic AMP elevation and pulsatile GH transcription [1]
College of Stomatology, Shanghai Jiao Tong University
Mild nausea or lightheadedness, especially during the first week Injection site discomfort, redness, or swelling Headache Rare: water retention or joint stiffness Your lab results could reveal changes in your hormones that require follow-up
It has no approved indication and is supplied at verified purity above 99% for laboratory research use only, with identity and purity confirmed against each batchs Certificate of Analysis
Researchers alternating between both timings across different cycle phases report the strongest overall body recomposition, but that requires meticulous tracking and protocol adherence most people don't maintain
Each vial is clearly labeled for research use.